SSBP1 mutations in dominant optic atrophy with variable retinal degeneration.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
09 2019
Historique:
received: 06 12 2018
revised: 10 07 2019
accepted: 10 07 2019
pubmed: 13 7 2019
medline: 14 4 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

Autosomal dominant optic atrophy (ADOA) starts in early childhood with loss of visual acuity and color vision deficits. OPA1 mutations are responsible for the majority of cases, but in a portion of patients with a clinical diagnosis of ADOA, the cause remains unknown. This study aimed to identify novel ADOA-associated genes and explore their causality. Linkage analysis and sequencing were performed in multigeneration families and unrelated patients to identify disease-causing variants. Functional consequences were investigated in silico and confirmed experimentally using the zebrafish model. We defined a new ADOA locus on 7q33-q35 and identified 3 different missense variants in SSBP1 (NM_001256510.1; c.113G>A [p.(Arg38Gln)], c.320G>A [p.(Arg107Gln)] and c.422G>A [p.(Ser141Asn)]) in affected individuals from 2 families and 2 singletons with ADOA and variable retinal degeneration. The mutated arginine residues are part of a basic patch that is essential for single-strand DNA binding. The loss of a positive charge at these positions is very likely to lower the affinity of SSBP1 for single-strand DNA. Antisense-mediated knockdown of endogenous ssbp1 messenger RNA (mRNA) in zebrafish resulted in compromised differentiation of retinal ganglion cells. A similar effect was achieved when mutated mRNAs were administered. These findings point toward an essential role of ssbp1 in retinal development and the dominant-negative nature of the identified human variants, which is consistent with the segregation pattern observed in 2 multigeneration families studied. SSBP1 is an essential protein for mitochondrial DNA replication and maintenance. Our data have established pathogenic variants in SSBP1 as a cause of ADOA and variable retinal degeneration. ANN NEUROL 2019;86:368-383.

Identifiants

pubmed: 31298765
doi: 10.1002/ana.25550
pmc: PMC8855788
mid: NIHMS1776215
doi:

Substances chimiques

DNA-Binding Proteins 0
Mitochondrial Proteins 0
RNA, Messenger 0
SSBP1 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

368-383

Subventions

Organisme : Medical Research Council
ID : G108/523
Pays : United Kingdom
Organisme : Fight for Sight Early Career Investigator Award
Pays : International
Organisme : Medical Research Council
ID : G0700949
Pays : United Kingdom
Organisme : Fight for Sight (UK)
Pays : International
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : GM63904
Pays : United States
Organisme : Clinician Scientist Fellowship Award
ID : G1002570
Pays : International
Organisme : Clinician Scientist Fellowship Award
ID : G108523
Pays : International
Organisme : Medical Research Council Project Grant
ID : G0700949
Pays : International
Organisme : Cancer Research United Kingdom
Pays : International
Organisme : UK National Institute of Health Research
Pays : International
Organisme : Medical Research Council (UK)
Pays : International
Organisme : Medical Research Council
ID : G108523
Pays : United Kingdom
Organisme : National Health Service
Pays : International
Organisme : NIGMS NIH HHS
ID : R01 GM063904
Pays : United States
Organisme : NIGMS NIH HHS
ID : R56 GM063904
Pays : United States
Organisme : NIHR Biomedical Research Centre
Pays : International
Organisme : National Institute for Health Research
Pays : International
Organisme : Isaac Newton Trust
Pays : International
Organisme : Medical Research Council
ID : G0701386
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1002570
Pays : United Kingdom

Informations de copyright

© 2019 American Neurological Association.

Références

Development. 1996 Dec;123:95-102
pubmed: 9007232
Genomics. 1995 Jan 20;25(2):559-64
pubmed: 7789991
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Protein Sci. 2004 Jun;13(6):1594-602
pubmed: 15133161
Nat Genet. 2000 May;25(1):12-3
pubmed: 10802644
Am J Hum Genet. 2017 Jan 5;100(1):75-90
pubmed: 28041643
Doc Ophthalmol. 2016 Aug;133(1):1-9
pubmed: 27443562
Hum Mutat. 2016 Mar;37(3):235-41
pubmed: 26555599
Doc Ophthalmol. 2013 Feb;126(1):1-7
pubmed: 23073702
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Mol Neurodegener. 2018 Oct 17;13(1):56
pubmed: 30333037
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Bioinformatics. 2005 Apr 15;21(8):1730-2
pubmed: 15377505
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Development. 1999 May;126(10):2129-40
pubmed: 10207138
Curr Opin Genet Dev. 2016 Jun;38:52-62
pubmed: 27065468
Eur J Hum Genet. 2019 Mar;27(3):494-502
pubmed: 30143805
Adv Exp Med Biol. 2018;1085:161-162
pubmed: 30578503
Brain. 2018 Jan 1;141(1):55-62
pubmed: 29182774
J Child Neurol. 2017 Aug;32(9):840-845
pubmed: 28545339
Nat Genet. 2014 Aug;46(8):912-918
pubmed: 25017105
Genes Dev. 1994 Jun 1;8(11):1311-23
pubmed: 7926732
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
PLoS Biol. 2007 Dec;5(12):e325
pubmed: 18076286
Dev Biol. 2011 Jan 15;349(2):213-24
pubmed: 21056553
Autophagy. 2013 Nov 1;9(11):1693-709
pubmed: 23939015
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Neuron. 2001 Jun;30(3):725-36
pubmed: 11430806
Annu Rev Biochem. 2007;76:679-99
pubmed: 17408359
J Cancer. 2017 May 12;8(8):1400-1409
pubmed: 28638454
Trends Biochem Sci. 2000 Mar;25(3):147-50
pubmed: 10694887
Methods Cell Biol. 1999;59:87-115
pubmed: 9891357
Am J Hum Genet. 2011 May 13;88(5):621-7
pubmed: 21549336
Doc Ophthalmol. 2018 Jun;136(3):199-206
pubmed: 29934802
Mol Neurobiol. 2019 Mar;56(3):1719-1736
pubmed: 29922981
Nat Struct Biol. 1997 Feb;4(2):153-7
pubmed: 9033597
Development. 2004 Mar;131(6):1331-42
pubmed: 14973290
PLoS Genet. 2017 Oct 19;13(10):e1007000
pubmed: 29049395
Mol Syst Biol. 2014 Aug 28;10:748
pubmed: 25170020
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Orphanet J Rare Dis. 2012 Jul 09;7:46
pubmed: 22776096
Nat Genet. 2000 Oct;26(2):216-20
pubmed: 11017081
Hum Mutat. 2003 Jun;21(6):577-81
pubmed: 12754702
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Eye Brain. 2011 Sep 26;3:29-47
pubmed: 28539774
JAMA Ophthalmol. 2017 Apr 1;135(4):339-347
pubmed: 28253385
Dev Biol. 2003 Jun 15;258(2):349-63
pubmed: 12798293

Auteurs

Neringa Jurkute (N)

Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
University College London Institute of Ophthalmology, University College London, London, United Kingdom.

Costin Leu (C)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.
Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH.
Genomic Medicine Institute, Lerner Research Institute Cleveland Clinic, Cleveland, OH.
Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.

Hans-Martin Pogoda (HM)

Institute for Zoology, Developmental Biology Unit, University of Cologne, Cologne, Germany.

Gavin Arno (G)

Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
University College London Institute of Ophthalmology, University College London, London, United Kingdom.

Anthony G Robson (AG)

Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
University College London Institute of Ophthalmology, University College London, London, United Kingdom.

Gudrun Nürnberg (G)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.

Janine Altmüller (J)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.

Holger Thiele (H)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.

Susanne Motameny (S)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.

Mohammad Reza Toliat (MR)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.

Kate Powell (K)

School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom.

Wolfgang Höhne (W)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.

Michel Michaelides (M)

Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
University College London Institute of Ophthalmology, University College London, London, United Kingdom.

Andrew R Webster (AR)

Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
University College London Institute of Ophthalmology, University College London, London, United Kingdom.

Anthony T Moore (AT)

Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
University College London Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Ophthalmology, University of California, San Francisco, San Francisco, CA.

Matthias Hammerschmidt (M)

Institute for Zoology, Developmental Biology Unit, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.

Peter Nürnberg (P)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.

Patrick Yu-Wai-Man (P)

Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom.
University College London Institute of Ophthalmology, University College London, London, United Kingdom.
Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom.
Cambridge Centre for Brain Repair and Medical Research Council Mitochondrial Biology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

Marcela Votruba (M)

School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom.
Cardiff Eye Unit, University Hospital Wales, Cardiff, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH